PERK Polyclonal Antibody

Eukaryotic translation initiation factor 2 alpha kinase 3 encoded by EIF2AK3 phosphorylates the alpha subunit of eukaryotic translation-initiation factor 2, leading to its inactivation, and thus to a rapid reduction of translational initiation and repression of global protein synthesis. Eukaryotic translation initiation factor 2 alpha kinase 3 is thought to modulate mitochondrial function. It is a type I membrane protein located in the endoplasmic reticulum (ER), where it is induced by ER stress caused by malfolded proteins. Mutations in EIF2AK3 are associated with Wolcott-Rallison syndrome.

The PERK Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of the protein kinase RNA-like endoplasmic reticulum kinase (PERK). This antibody is produced using advanced techniques to ensure exceptional quality and performance.

With its exceptional specificity, the PERK Polyclonal Antibody enables accurate identification and quantification of PERK in various biological samples. It has been extensively validated for use in Western blotting, immunohistochemistry, and immunofluorescence applications.

The PERK Polyclonal Antibody exhibits excellent sensitivity, allowing for the detection of low levels of PERK expression. Its robust performance ensures reliable and reproducible results, making it an ideal choice for both research and diagnostic purposes.

This antibody is supplied as a liquid formulation, ready for immediate use. It is provided in a convenient size, allowing for multiple experiments without the need for frequent reordering. The PERK Polyclonal Antibody is compatible with a wide range of experimental conditions and can be used in various species, including human, mouse, and rat.

Choose the PERK Polyclonal Antibody for its exceptional specificity, sensitivity, and reliability. It is an indispensable tool for researchers and clinicians alike, facilitating the study of PERK and its role in cellular processes, disease mechanisms, and therapeutic interventions.